Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
作者： Carlo Patrono , Barry Coller , Garret A. FitzGerald , Jack Hirsh , Gerald Roth
DOI: 10.1378/CHEST.126.3_SUPPL.234S
关键词:
摘要: This article discusses platelet active drugs as part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …
sci-hub.se 参考文章(317)
Fernando Boullon, Jorge Rouvier, Raul Raca, Luis de la Fuente, Rene Favaloro, Raul Altman, Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 72, pp. 127- 129 ,(1976) , 10.1016/S0022-5223(19)40105-0
Michael Rolf Mueller, Andreas Salat, Petra Stangl, Marco Murabito, Sad Pulaki, Dagmar Boehm, Renate Koppensteiner, Erdem Ergun, Martina Mittlboeck, Wolfgang Schreiner, Udo Losert, Ernst Wolner, Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thrombosis and Haemostasis. ,vol. 78, pp. 1003- 1007 ,(1997) , 10.1055/S-0038-1657677
Marian T. Nakada, Patricia M. Sassoli, Susan H. Tam, Mark A. Nedelman, Robert E. Jordan, Dean J. Kereiakes, Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates. Journal of Thrombosis and Thrombolysis. ,vol. 14, pp. 15- 24 ,(2002) , 10.1023/A:1022058103581
Iris Müller, Felicitas Besta, Christian Schulz, Steffen Massberg, Albert Schönig, Meinrad Gawaz, Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thrombosis and Haemostasis. ,vol. 89, pp. 783- 787 ,(2003) , 10.1055/S-0037-1613462
, Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale Annals of Internal Medicine. ,vol. 136, pp. 157- ,(2002) , 10.7326/0003-4819-136-2-200201150-00015
Dean J. Kereiakes, Michele Mueller, Wendy Howard, Pam Lacock, Linda C. Anderson, Thomas M. Broderick, Eli M. Roth, Charles W. Abbottsmith, Efficacy of abciximab induced platelet blockade using a rapid point of care assay. Journal of Thrombosis and Thrombolysis. ,vol. 7, pp. 265- 276 ,(1999) , 10.1023/A:1008931126871
Debabrata Mukherjee, David J. Moliterno, Applications of Anti-Platelet Monitoring in Catheterization Laboratory Journal of Thrombosis and Thrombolysis. ,vol. 9, pp. 293- 301 ,(2000) , 10.1023/A:1018724827741
R.L. Lorenz, M. Weber, J. Kotzur, K. Theisen, C.V. Schacky, W. Meister, B. Reichardt, P.C. Weber, IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY): Effects on Platelet Aggregation and Thromboxane Formation The Lancet. ,vol. 323, pp. 1261- 1264 ,(1984) , 10.1016/S0140-6736(84)92446-2
Roberto Latini, Gianni Tognoni, Aldo P. Maggioni, MariaGrazia Franzosi, Eugenio Santoro, Colin Baigent, Zheng-Ming Chen, Rory Collins, Richard Peto, Peter Sleight, Eugene Braunwald, Marc Pfeffer, Marcus Flather, John Kjekshus, Lars Køber, Li-Sheng Liu, Wen Wang, Fabrizio Pizzetti, Karl Swedberg, Luigi Tavazzi, Salim Yusuf, Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. Journal of the American College of Cardiology. ,vol. 35, pp. 1801- 1807 ,(2000) , 10.1016/S0735-1097(00)00638-0